Abstract The era of targeted therapies has seen significant improvements in depth of response, progression-free survival, and overall survival for patients with multiple myeloma. Despite these improvements in clinical outcome, patients inevitably relapse and require further treatment. Drug-resistant...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!